The value of radiotherapy in prolonging survival of patients with tumour on the bronchial stump after surgical resection for bronchial carcinoma has never been shown convincingly. A review is reported of the effect of radiotherapy in two clinically different types of case: (a) postoperative patients with reported microscopic tumour of the mucosa of the resected bronchial margin, and (b) patients with macroscopic recurrence of tumour in the bronchial stump, detected bronchoscopically some time after surgery.
Patients and methods
The records of 1000 patients who had undergone lobectomy or pneumonectomy for bronchial carcinoma during 1966-75 were examined. Two series of cases (not mutually exclusive) were selected.
The first series consisted of 26 cases with tumour of the mucosa of the resected bronchial margin reported histologically at the time of surgery (excluding carcinoma in situ). Some clinicians routinely gave postoperative radiotherapy to such patients; as a consequence of this policy 12 of the 26 patients were treated by external megavoltage radiotherapy (4200-5000 rads). The interval between surgery and the commencement of radiotherapy was from one to three months; the duration of radiotherapy was from four to six weeks.
The policy of other clinicians was not to irradiate such patients, so that the remaining 14 patients did not receive radiotherapy. These non-irradiated patients have been used as a control group. No patient in either the irradiated or the non-irradiated group had evidence of distant metastases at presentation or evidence of residual tumour on the postoperative chest radiograph. Patients with evidence of extrapulmonary spread or lymph-node metastasis at surgery, or with histological evidence of tumour invasion of the outer wall of the resected bronchial margin, were not included. All tumours were squamous-cell carcinomas.
The second series consisted of 17 patients who had presented several months or years after surgery with recurrence of tumour in the bronchial stump ( In seven of these 17 patients tumour on the resected bronchial margin had been detected histologically at the time of surgery; these seven cases were therefore included in the first series also. Three of the seven patients had received postoperative radiotherapy. Tumour had not been detected on the resected bronchial margin in the remaining 10 patients. No case had evidence of lymph-node metastasis or invasion of mediastinal structures by tumour at surgery. These 17 patients had all presented with recent haemoptysis but no other symptoms, and had no radiographic evidence of tumour recurrence. They had all been cigarette smokers, but stopped smoking at the time of their original presentation. All tumours were squamous-cell carcinomas in this series also. Pneumonectomy had been performed in four cases, lobectomy in nine, and lobectomy with sleeve resection of the main bronchus in four.
Fourteen patients were irradiated after confirmation of the recurrence-three by bronchoscopic implantation of radioactive gold grains and 11 by external megavoltage radiotherapy (5000-6100 rads (50-61 Gy) over five to seven weeks). Three, in whom the recurrent tumour was more extensive, were not irradiated.
Results

POSTOPERATIVE RADIOTHERAPY
In the series of 26 cases with tumour of the resected bronchial margin reported histologically at the time of surgery, five of the 12 irradiated patients and four of the 14 non-irradiated patients survived five years. The difference was not significant. Three of the 12 irradiated and four of the 14 non-irradiated cases developed subsequent macroscopic stump recurrence of tumour. No patient in either group developed a bronchopleural fistula.
RADIOTHERAPY FOR SUBSEQUENT BRONCHIAL STUMP RECURRENCE OF TUMOUR
The survival of the 17 patients with bronchoscopically proved recurrence of tumour at the bronchial stump is shown in the table.
The six patients in whom tumour was detected when confined to the bronchial stump region were all given radiotherapy. One died of distant metastases after only four months. Of the remaining five, three are still alive, having survived five, eight, and 10 years from bronchoscopic confirmation of tumour recurrence. Repeat bronchoscopy after radiotherapy showed no macroscopic evidence of tumour in the bronchial stump, and biopsies gave negative results. The other two died of heart disease after five years, with no evidence of tumour recurrence at necropsy.
Of the 11 patients whose recurrent tumour was more extensive at the time of bronchoscopy, the three non-rradiated ones all survived less than a year, while survival in the eight irradiated patients was from 11 to 46 months ( The value of postoperative radiotherapy for residual tumour has not been clearly determined.'3 It did not appear to have been of benefit in the patients tabulated by Jeffery.4 Guttmann irradiated 20 patients after incomplete resection of bronchial carcinoma, including four with the bronchial margin affected, without apparent benefit.5 In the present study the five-year survival rate and the rate of subsequent recurrence of tumour at the bronchial stump in cases of histologically reported tumour of the mucosa of the resected bronchial margin were similar in patients given postoperative radiotherapy and in non-irradiated patients. Although the study was retrospective, a degree of randomisation was present in that the selection of patients to be irradiated was determined by the policies of different clinicians; no differences in prognostic features were apparent between the two groups. But 
